Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Vaccine|March 4, 2010
The Health Technology Assessment of bivalent HPV vaccine Cervarix in ItalyGiuseppe La Torre, Chiara de Waure, Giacomina Chiaradia, et al.Internal and Emergency Medicine|November 6, 2009
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysisStefano Capri, Walter Ageno, Davide Imberti, et al.World Journal of Clinical Cases|December 18, 2014
Relational coordination and healthcare management in lung cancerJosé Antonio Vinagre Romero, Juan Del Llano Señarís, Carmen De Pablos Heredero, et al.Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and DrugsAlessandra Romandini, Damiano Baldassarre, Stefano Genovese, et al.International Journal of Technology Assessment in Health Care|July 11, 2018
DEFINING INNOVATION WITH RESPECT TO NEW MEDICINES: A SYSTEMATIC REVIEW FROM A PAYER PERSPECTIVEOriol de Solà-Morales, David Cunningham, Mathias Flume, et al.Clinical Drug Investigation|August 1, 2008
Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspectiveHiltrud Liedgens, Nadine Hertel, Anja Gabriel, et al.Human Vaccines|August 26, 2011
Guidance for future HTA applications to vaccines: the HPV lessonGiuseppe La Torre, Chiara de Waure, Giacomina Chiaradia, et al.Journal of Market Access & Health Policy|May 27, 2016
Feasibility and attractiveness of indication value-based pricing in key EU countriesMathias Flume, Marc Bardou, Stefano Capri, et al.Journal of Medical Economics|October 20, 2020
An updated cost-effectiveness analysis of pazopanib versus sunitinib as first-line treatment for locally advanced or metastatic renal cell carcinoma in ItalyStefano Capri, Camillo Porta, Claudia Condorelli, et al.Human Vaccines & Immunotherapeutics|January 19, 2012
Economic value of influenza vaccinationChiara de Waure, Maria Assunta Veneziano, Chiara Cadeddu, et al.Pageof 8